• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NEW RENIN INHIBITORS - STABILITY AND ACTIVITY DETERMINATION. PART IV.

作者信息

Marszalek Dorota, Goldnik Anna, Winiecka Iwona, Jaworsk Pawel

出版信息

Acta Pol Pharm. 2017 Mar;74(2):393-399.

PMID:29624244
Abstract

A series of new seven potential renin inhibitors containing pseudodipeptides were synthesized. Stability for all compounds (1-7) in homogenates of liver, kidney, lung and in serum, gastric, intestinal juice and in the presence of α-chymotrypsin was determined. Compound 1 was unstable in all determined mediums. Compounds 2, 4, 5 and 7 were unstable, compound 3 was stable, compound 6 was unstable only in α-chy-motrypsin solution. Inhibitory activity of the compounds was measured in vitro by HPLC determination of low-ering concentration of substrate (angiotensinogen) in the presence of renin and the potential renin inhibitor (compounds 1-7). Compounds 1, 2, 4, 5, 6 and 7 showed inhibitory activity (1.12 x 10⁻⁷, 0.96 x 10⁻⁶, 1.58 x10⁻⁷,1.68 x 10⁻⁶, 1.30 x 10⁻⁶, 0.96 x 10⁻⁷M, respectively).

摘要

相似文献

1
NEW RENIN INHIBITORS - STABILITY AND ACTIVITY DETERMINATION. PART IV.
Acta Pol Pharm. 2017 Mar;74(2):393-399.
2
NEW RENIN-INHIBITORS--STABILITY AND ACTIVITY DETERMINATION. PART III.新型肾素抑制剂——稳定性与活性测定。第三部分。
Acta Pol Pharm. 2016 Mar-Apr;73(2):329-36.
3
New renin inhibitors--stability and activity determination. Part I.新型肾素抑制剂——稳定性与活性测定。第一部分。
Acta Pol Pharm. 2014 Jul-Aug;71(4):545-53.
4
New renin inhibitors--stability and activity determination. Part II.新型肾素抑制剂——稳定性与活性测定。第二部分。
Acta Pol Pharm. 2014 Jul-Aug;71(4):555-61.
5
The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.带有羟乙烯二肽等排体类似物的P1N-异丙基基序的阿利吉仑是人体天冬氨酰蛋白酶肾素的体外强效抑制剂。
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4863-7. doi: 10.1016/j.bmcl.2009.05.128. Epub 2009 Jun 26.
6
Total synthesis of "aliskiren": the first Renin inhibitor in clinical practice for hypertension.阿利克仑的全合成:首个用于高血压临床治疗的肾素抑制剂。
Org Lett. 2010 Apr 16;12(8):1816-9. doi: 10.1021/ol100427v.
7
Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.基于结构的药物设计:新型非肽类人肾素口服活性抑制剂的发现
Chem Biol. 2000 Jul;7(7):493-504. doi: 10.1016/s1074-5521(00)00134-4.
8
Renin inhibitors inhibited the activity of recombinant human renin but not activity in healthy human plasma.肾素抑制剂可抑制重组人肾素的活性,但对健康人血浆中的活性无抑制作用。
Clin Lab. 2012;58(3-4):291-8.
9
Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.2,7-二烷基取代的5(S)-氨基-4(S)-羟基-8-苯基辛烷甲酰胺P2'位的结构修饰:阿利吉仑的发现,一种强效非肽类人肾素抑制剂,在狨猴中每日给药一次后具有活性。
J Med Chem. 2007 Oct 4;50(20):4832-44. doi: 10.1021/jm070316i. Epub 2007 Sep 8.
10
Aliskiren therapy will have minimal effect on intracellular renin of renin-producing cells.阿利吉仑治疗对肾素生成细胞的细胞内肾素影响极小。
Hypertension. 2009 Feb;53(2):e17; author reply e18. doi: 10.1161/HYPERTENSIONAHA.108.126722. Epub 2009 Jan 5.